Skip to main content
Premium Trial:

Request an Annual Quote

TriLink, Li-Cor Ink Oligo Dye Deal

NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that it has inked a licensing deal with Li-Cor Biosciences covering labeling of nucleic acids with near-infrared dyes.

Under the alliance, TriLink's oligonucleotides, nucleotides, and nucleosides will be custom labeled with Li-Cor's IRDye near-infrared dyes. The dyes offer enhanced sensitivity due to low background autofluorescence, TriLink said.

Financial and other terms of the agreement were not disclosed.

"[W]e are continually expanding our portfolio of available modifications," Richard Hogrefe, TriLink president and CEO, said in a statement. "The innovative LI-COR infrared dye series, IRDye 650-800, is a perfect fit, opening new doors for our customers seeking enhanced signal-to-noise ratios and dynamic range in applications where autofluorescence is an issue."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more